Ethics Subcommittee, Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), 59534-59535 [E7-20696]
Download as PDF
<![CDATA[
59534
Federal Register / Vol. 72, No. 203 / Monday, October 22, 2007 / Notices
Dated: October 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. E7–20692 Filed 10–19–07; 8:45 am]
Dated: October 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. E7–20701 Filed 10–19–07; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Establishment
ebenthall on PRODPC61 with NOTICES
Dated: October 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. E7–20717 Filed 10–19–07; 8:45 am]
Notice of Establishment
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
Appendix 2), the Secretary, Department
of Health and Human Services (HHS),
announces the establishment of the
Board of Scientific Counselors, National
Center for Health Marketing (NCHM).
This board is established to ensure
that the national center has access to
external viewpoints, the capacity to
conduct peer review of scientific
programs, and perform second level
peer-review of research applications.
The Board of Scientific Counselors,
NCHM will advise the Secretary, HHS;
and the Director, Centers for Disease
Control and Prevention; concerning
strategies and goals for the programs
and research within the national
centers; shall conduct peer-review of
scientific programs; and monitor the
overall strategic direction and focus of
the national centers. The board, after
conducting its periodic reviews, shall
submit a written description of the
results of the review and its
recommendations to the Director, CDC.
The board shall also perform secondlevel peer review of applications for
grants-in-aid for research and research
training activities, cooperative
agreements, and research contract
proposals relating to the broad areas
within the national centers.
For information, contact Dr. Kathleen
McDuffie, Executive Secretary, Centers
for Disease Control and Prevention, of
the Department of Health and Human
Services, 1600 Clifton Road, N.E.,
Mailstop E21, Atlanta, Georgia 30333,
telephone 404/498–1114 or fax 404/
498–1112.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the CDC
and the Agency for Toxic Substances
and Disease Registry.
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
Appendix 2), the Secretary, Department
of Health and Human Services (HHS),
announces the establishment of the
Board of Scientific Counselors, National
Center for Injury Prevention and Control
(NCIPC).
This board is established to ensure
that the national center has access to
external viewpoints, the capacity to
conduct peer review of scientific
programs, and perform second level
peer-review of research applications.
The Board of Scientific Counselors,
NCIPC will advise the Secretary, HHS;
and the Director, Centers for Disease
Control and Prevention (CDC);
concerning strategies and goals for the
programs and research within the
national centers; shall conduct peerreview of scientific programs; and
monitor the overall strategic direction
and focus of the national centers. The
board, after conducting its periodic
reviews, shall submit a written
description of the results of the review
and its recommendations to the
Director, CDC. The board shall also
perform second-level peer review of
applications for grants-in-aid for
research and research training activities,
cooperative agreements, and research
contract proposals relating to the broad
areas within the national centers.
For information, contact Dr.
Gwendolyn Cattledge, Executive
Secretary, Centers for Disease Control
and Prevention, of the Department of
Health and Human Services, 4770
Buford Highway, NE., Mailstop K02,
Atlanta, Georgia 30341, telephone 770/
488–4655 or fax 770/488–4422.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the CDC
and the Agency for Toxic Substances
and Disease Registry.
Ethics Subcommittee, Advisory
Committee to the Director (ACD),
Centers for Disease Control and
Prevention (CDC)
VerDate Aug<31>2005
16:04 Oct 19, 2007
Jkt 214001
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC announces the
following meeting for the
aforementioned subcommittee:
Times and Dates:
1 p.m.–5:30 p.m., November 15, 2007.
8:30 a.m.–3:30 p.m., November 16, 2007.
Place: CDC, Century Center Campus, 1825
Century Boulevard, Conference Room 1 A/B,
Atlanta, Georgia 30345.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 70 people. To
accommodate public participation in the
meeting, a conference telephone line will be
available. The public is welcome to
participate during the public comment
periods by calling (866) 919–3560 and
entering code 4168828. The public comment
periods are tentatively scheduled from 4:45
p.m.–5 p.m. on November 15, 2007 and from
3 p.m.–3:15 p.m. on November 16, 2007.
Purpose: The Ethics Subcommittee will
provide counsel to the ACD, CDC regarding
a broad range of public health ethics
questions and issues arising from programs,
scientists, and practitioners.
Matters to be Discussed: Agenda items will
include: Ethical Guidance for Public Health
Emergency Preparedness and Response;
Ethical Guidance for Non-Research Data
Collections; and Updates on Activities
relating to CDC Partnerships, Genomics Best
practices, and Pandemic Influenza
Preparedness. Agenda items are subject to
change as priorities dictate.
For security reasons, members of the
public interested in attending the meeting
should contact the person below. The
deadline for notification of attendance is
November 9, 2007.
Contact Person for More Information: Drue
Barrett, Ph.D., Designated Federal Official,
Ethics Subcommittee, CDC, 1600 Clifton
Road, NE., M/S D–50, Atlanta, Georgia
30333. Telephone (404) 639–4690. E-mail:
dbarrett@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
E:\FR\FM\22OCN1.SGM
22OCN1
59535
Federal Register / Vol. 72, No. 203 / Monday, October 22, 2007 / Notices
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: October 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–20699 Filed 10–19–07; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: October 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. E7–20696 Filed 10–19–07; 8:45 am]
Dated: October 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–20688 Filed 10–19–07; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Centers for Disease
Control and Prevention (CDC) Grants
for Public Health Research
Dissertation, Program Announcement
(PA) PAR 07–231, Panel A
Correction: This notice was published
in the Federal Register on October 10,
2007, Volume 72, Number 195, page
57582. The time and date should read
as follows:
Time and Date: 8:30 a.m.–5 p.m.,
November 15, 2007 (Closed).
Contact Person for More Information:
Juliana Cyril, PhD, MPH, Scientific
Review Administrator, Office of the
Chief Science Officer, CDC, 1600 Clifton
Road, NE., Mailstop D 72, Atlanta, GA
30333. Telephone (404) 639–4896.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Correction: This notice was published
in the Federal Register on October 11,
2007, Volume 72, Number 196, page
57947–57948. The Place should read as
follows:
Place: Department of Health and
Human Services Building, 395 E Street,
SW., Suite 9100, Washington, DC 20201.
Contact Person for More Information:
Angela B. Scott, Committee
Management Specialist, HICPAC,
Division of Healthcare Quality
Promotion, NCPDCID, CDC, 1600
Clifton Road, N.E., Mailstop A 45,
Atlanta, GA 30333. Telephone (404)
639–1526.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Proposed Information Collection
Activity; Comment Request; Proposed
Project
Title: Compassion Capital Fund
Impact Evaluation Process Study.
OMB No.: New Collection.
Description: The information
collection activity proposed under this
notice will obtain information about
intermediary grantee agencies providing
capacity building assistance to faithbased and community organizations
under the Compassion Capital Fund
(CCF) Demonstration program. The
information gathered under this data
collection activity will be used to
describe the approach and methods
used by intermediaries to provide the
services that are being evaluated in the
CCF impact evaluation. Information
collection will be through informal
discussions and observations on-site at
the organizations, using uniform
protocols.
Respondents: Directors and staff
providing technical assistance and
related services to faith-based and
community organizations and directors
and staff in faith-based and community
organizations that have received
capacity building assistance.
ANNUAL BURDEN ESTIMATES
Number of respondents
Instrument
Number of responses per
respondent
Average burden hours per
response
10
30
30
60
1
1
1
1
3
1
2
1
ebenthall on PRODPC61 with NOTICES
Intermediary Protocol for Executive Director ...................................................
Intermediary Protocol for Key Staff .................................................................
Faith-based or Community Organization Protocol for Executive Director ......
Faith-based or Community Organization Protocol for Key Staff .....................
Estimated Total Annual Burden
Hours: 180.
In compliance with the requirements
of Section 3506(c)(1)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
VerDate Aug<31>2005
15:02 Oct 19, 2007
Jkt 214001
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447. Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
Total burden
hours
30
30
60
60
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
E:\FR\FM\22OCN1.SGM
22OCN1
]]>Agencies
[Federal Register Volume 72, Number 203 (Monday, October 22, 2007)]
[Notices]
[Pages 59534-59535]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-20696]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Ethics Subcommittee, Advisory Committee to the Director (ACD),
Centers for Disease Control and Prevention (CDC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), CDC announces the following meeting for
the aforementioned subcommittee:
Times and Dates:
1 p.m.-5:30 p.m., November 15, 2007.
8:30 a.m.-3:30 p.m., November 16, 2007.
Place: CDC, Century Center Campus, 1825 Century Boulevard,
Conference Room 1 A/B, Atlanta, Georgia 30345.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 70 people. To
accommodate public participation in the meeting, a conference
telephone line will be available. The public is welcome to
participate during the public comment periods by calling (866) 919-
3560 and entering code 4168828. The public comment periods are
tentatively scheduled from 4:45 p.m.-5 p.m. on November 15, 2007 and
from 3 p.m.-3:15 p.m. on November 16, 2007.
Purpose: The Ethics Subcommittee will provide counsel to the
ACD, CDC regarding a broad range of public health ethics questions
and issues arising from programs, scientists, and practitioners.
Matters to be Discussed: Agenda items will include: Ethical
Guidance for Public Health Emergency Preparedness and Response;
Ethical Guidance for Non-Research Data Collections; and Updates on
Activities relating to CDC Partnerships, Genomics Best practices,
and Pandemic Influenza Preparedness. Agenda items are subject to
change as priorities dictate.
For security reasons, members of the public interested in
attending the meeting should contact the person below. The deadline
for notification of attendance is November 9, 2007.
Contact Person for More Information: Drue Barrett, Ph.D.,
Designated Federal Official, Ethics Subcommittee, CDC, 1600 Clifton
Road, NE., M/S D-50, Atlanta, Georgia 30333. Telephone (404) 639-
4690. E-mail: dbarrett@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for
[[Page 59535]]
both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: October 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. E7-20696 Filed 10-19-07; 8:45 am]
BILLING CODE 4163-18-P
